RecruitingNCT07076147

Breast Cancer Screening Adherence for Women at Moderate Risk for Breast Cancer


Sponsor

University of Southern California

Enrollment

150 participants

Start Date

Jun 2, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

This study assesses breast cancer screening adherence for women at moderately increased risk for developing breast cancer based on gene mutation status or empiric risk model estimates. It also seeks to determine facilitators and barriers to screening.


Eligibility

Sex: FEMALEMin Age: 30 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This study is looking at how well women at moderate genetic risk for breast cancer keep up with recommended screening (mammograms and/or MRI scans) over time. **You may be eligible if...** - You are a woman between 30 and 75 years old - You have a genetic test result showing a moderately increased breast cancer risk due to variants in genes such as ATM, CHEK2, BARD1, RAD51C, or RAD51D, OR your calculated lifetime breast cancer risk is between 20–40% - You received a breast cancer risk assessment at USC Norris or LA General Hospital starting in 2021 and at least 12 months ago - You were recommended to get annual breast MRI and/or mammogram at the time of your assessment - You speak English or Spanish **You may NOT be eligible if...** - You have a previous personal history of breast cancer before your genetic counseling - You had metastatic cancer at the time of your risk assessment - You are deceased - You have already had preventive breast surgery (e.g., mastectomy) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNon-Interventional Study

Non-interventional study


Locations(2)

Los Angeles General Medical Center

Los Angeles, California, United States

USC / Norris Comprehensive Cancer Center

Los Angeles, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07076147


Related Trials